MedComm – Oncology
Last updated ISSN 2769-6448
MedComm – Oncology is published by Wiley in medicine. It is open access. There is no article processing charge.
Is your paper a fit?
The surest way to know is to compare your own abstract against what this journal has actually been publishing, rather than against its aims-and-scope page. Paste your abstract and Journal Hunt will tell you how close MedComm – Oncology is — and show you journals like it.
What it publishes
Recent work in MedComm – Oncology concentrates on these topics, taken from its published record rather than from its own description:
- Cancer Immunotherapy and Biomarkers
- Cancer, Hypoxia, and Metabolism
- Nanoplatforms for cancer theranostics
- Ferroptosis and cancer prognosis
- Epigenetics and DNA Methylation
- Cancer Cells and Metastasis
- Cancer Research and Treatments
- RNA modifications and cancer
- Protein Degradation and Inhibitors
- Immune cells in cancer
Key facts
| Publisher | Wiley |
|---|---|
| ISSN | 2769-6448 |
| Subject area | Medicine |
| Access | Open access |
| Article processing charge | None |
| Indexed in | DOAJ |
| Articles published | 206 |
| Publishing since | 2022 |
Facts come from OpenAlex, DOAJ and Wikidata and may lag the journal’s own pages. Check the publisher’s site before submitting. Indexing shown here is what is recorded, not a complete picture — about a third of journals have no indexing recorded anywhere we can read, so “not recorded” does not mean a journal is absent from Scopus or Web of Science.
Journals like MedComm – Oncology
Other established journals in medicine, if this one is not the right home for your paper: